OCULOCUTANEOUS ALBINISM (OCA)

Clinical trials for OCULOCUTANEOUS ALBINISM (OCA) explained in plain language.

Never miss a new study

Get alerted when new OCULOCUTANEOUS ALBINISM (OCA) trials appear

Sign up with your email to follow new studies for OCULOCUTANEOUS ALBINISM (OCA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First-Ever gene therapy trial aims to restore vision in children with albinism

Disease control Recruiting now

This early-stage study is testing a new gene therapy called JWK010 for children aged 5-12 with a specific type of albinism (OCA1). The goal is to see if a single injection into the eye is safe and can help the body produce pigment, which may improve vision and eye structure. Rese…

Matched conditions: OCULOCUTANEOUS ALBINISM (OCA)

Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

OCULOCUTANEOUS ALBINISM (OCA)

Get alerted when new OCULOCUTANEOUS ALBINISM (OCA) trials appear

First-Ever gene therapy trial aims to restore vision in children with albinism